Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
COVID-19: New lockdowns as vaccine trials stumble
As Europe imposed new restrictions to try to stall a surging second wave of the novel coronavirus, hopes for vaccines to rapidly provide relief suffered a blow with the suspension of two clinical trials in the United States.
China rushed to test an entire city of nine million within days after a minor coronavirus outbreak in the sprawling country and Europe struggled to tackle a new surge of infections.
The virus is still spreading rapidly worldwide, with over one million deaths and 37 million infections.
Many nations that suppressed their first outbreaks now face a second wave.
Hopes for a rapid vaccine rollout suffered a setback as US pharmaceutical firm Eli Lilly said on Tuesday it had suspended the Phase 3 trial of its antibody treatment over an unspecified incident, the second in less than 24 hours after Johnson Johnson ran into a similar problem.
In Europe, the Netherlands imposed a “partial lockdown” to curb one of the region’s worst coronavirus surges, with all bars, cafes and restaurants to close and non-medical face coverings mandatory in all indoor spaces for people aged over 13.
In the United Kingdom, Labour opposition leader Keir Starmer called for a two-to-three-week “circuit break” lockdown to slow the rates, saying the government had “lost control” of the outbreak having ignored stringent measures suggested by scientific experts on September 21.
style="width: 100%; height: 100%; position: absolute; top: 0; bottom: 0; right: 0; left: 0;">
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks